Prostate cancer (PCa) is the second leading cause of cancer‐related deaths in Western male population. Previous studies have demonstrated that differential display code 3 (DD3 or DD3PCA3) is one of the most PCa‐specific genes; therefore, it has been used as a clinical diagnostic marker for PCa. In this study, we constructed an oncolytic adenovirus Ad.DD3‐E1A by using the minimal DD3 promoter to replace the native viral promoter of E1A gene. In addition, Ad.DD3‐E1A was armed with therapeutic gene IL‐24 to enhance its antitumor activity. The resulting adenovirus, Ad.DD3‐E1A‐IL‐24, demonstrated PCa specificity and excellent antitumor effect. Further analyses on its antitumor mechanism revealed that it has the capacity to induce apoptosis in PCa cells and inhibit angiogenesis. These results suggest that Ad.DD3‐E1A‐IL‐24 is a promising antitumor agent that may be able to be used in the future as a treatment for PCa.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.